However, Cengiz et al. showed that polymorphisms in the IL-6 and IL-8 genes do not appear to have a role in the pathophysiology of NASH or liver fibrosis [56]. The gene discussed is CXCL8; the disease is metabolic dysfunction-associated steatohepatitis.